Efficacy and Safety of Tirzepatide in Overweight and Obese Adult Patients with Type 1 Diabetes

Overview of attention for article published in Diabetes Technology & Therapeutics, April 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#33 of 1,552)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 11 news outlets
blogs: 1 blog

twitter: 3 X users

Readers on

mendeley: 2 Mendeley

Summary News Blogs X

So far, Altmetric has seen 11 news stories from 11 outlets.

Study: Tirzepatide Results in Weight Loss for Individuals With Type 1 Diabetes

Pharmacy Times, 01 Apr 2024

Tirzepatide (Zepbound; Lilly) resulted in an average of 18.5% weight loss and improved glucose control in patients with type 1…

Efficacy and safety of tirzepatide in overweight and obese individuals with type 1 diabetes

MSN, 26 Mar 2024

A new study published in the journal Diabetes Technology

Type 2 Diabetes Medication Tirzepatide May Help Obese Type 1 Diabetics Also

Science 2.0, 25 Mar 2024

Tirzepatide facilitates weight loss in obese people with type 2 diabetes and therefore improves glucose control and also…

Efficacy and safety of tirzepatide in overweight and obese individuals with type 1 diabetes

MedicalXpress, 25 Mar 2024

A new study published in the journal Diabetes Technology

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 7 additional news stories.